Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase II trial to study the effectiveness of ixabepilone in treating patients who
have metastatic or recurrent head and neck cancer. Drugs used in chemotherapy use different
ways to stop tumor cells from dividing so they stop growing or die